Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy.
| Revenue (Most Recent Fiscal Year) | $1.19B |
| Net Income (Most Recent Fiscal Year) | $127.45M |
| PE Ratio (Current Year Earnings Estimate) | 42.65 |
| PE Ratio (Trailing 12 Months) | 46.07 |
| PEG Ratio (Long Term Growth Estimate) | 2.43 |
| Price to Sales Ratio (Trailing 12 Months) | 6.27 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.92 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 34.18 |
| Pre-Tax Margin (Trailing 12 Months) | 15.70% |
| Net Margin (Trailing 12 Months) | 11.73% |
| Return on Equity (Trailing 12 Months) | 10.34% |
| Return on Assets (Trailing 12 Months) | 6.21% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.79 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.22 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.25 |
| Inventory Turnover (Trailing 12 Months) | 3.08 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.02 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.12 |
| Earnings per Share (Most Recent Fiscal Year) | $0.52 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.54 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 302.84M |
| Free Float | 300.72M |
| Market Capitalization | $7.81B |
| Average Volume (Last 20 Days) | 0.27M |
| Beta (Past 60 Months) | 0.57 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.70% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |